Atul announced that its wholly owned subsidiary, Atul Healthcare has entered into a binding shareholders agreement with Valsad Institute of Medical Sciences (VIMS) and its existing shareholders which comprise medical doctors and their relatives / associates. The Agreement executed on 04 October 2022 provides for acquisition of 13,50,000 equity shares of Rs 100 each constituting 50% of the total equity share capital at an issue price of Rs 166.67 per equity share of VIMS by AHCL and other terms and conditions. Atul will be investing in the said equity shares of AHCL to complete the above transaction. Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
